Sort   by:  
 Page size 
UnknownDevelopment of a salivary autoantibody biomarker panel for diagnosis of oral cavity squamous cell carcinoma.
Not available
S-EPMC9659860 | biostudies-literature
UnknownComparing Efficacy and Safety Between Patients With Atrial Fibrillation Taking Direct Oral Anticoagulants or Warfarin After Direct Oral Anticoagulant Failure.
Not available
S-EPMC10727336 | biostudies-literature
UnknownSustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis.
Not available
S-EPMC7096452 | biostudies-literature
UnknownSuccessful Antiviral Therapy Reduces Risk of Schizophrenia Among Chronic Hepatitis C Patients: A Nationwide Real-World Taiwanese Cohort (T-COACH).
Not available
S-EPMC7751132 | biostudies-literature
UnknownImpact of Hepatitis C Virus Clearance on Cardiovascular Risk: A Real-World Experience From the Nationwide Taiwan Hepatitis C Virus Registry.
Not available
S-EPMC12407379 | biostudies-literature
UnknownClinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes.
Not available
S-EPMC5669573 | biostudies-literature
UnknownMetformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy.
Not available
S-EPMC11261235 | biostudies-literature
UnknownFactors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan.
Not available
S-EPMC8252422 | biostudies-literature
UnknownNationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan.
Not available
S-EPMC8648748 | biostudies-literature
UnknownEffectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naive patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry.
Not available
S-EPMC10042416 | biostudies-literature
Sort   by:  
 Page size